| Authors: |
Remmel HL; Atossa Therapeutics, Inc., Seattle, WA, USA.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics and Cell and Developmental Biology, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Drukier Institute for Children's Health and Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA., Hammer SS; Atossa Therapeutics, Inc., Seattle, WA, USA., Neff LA; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland., Dorchies OM; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.; Université Grenoble Alpes, Inserm U1055, Laboratory of Fundamental and Applied Bioenergetics, Grenoble, France., Scapozza L; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland., Fischer D; Division of Pediatric Neurology and Developmental Medicine, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland., Quay SC; Atossa Therapeutics, Inc., Seattle, WA, USA. |
